We are live on ! Find out more
VCA

Verdence Capital Advisors Portfolio holdings

AUM $1.9B
1-Year Est. Return 36.41%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+36.41%
3 Year Est. Return
+97.11%
5 Year Est. Return
+121.09%
10 Year Est. Return
AUM
$883M
AUM Growth
+$33.1M
Cap. Flow
+$65.7M
Cap. Flow %
7.44%
Top 10 Hldgs %
21.3%
Holding
549
New
44
Increased
336
Reduced
104
Closed
39

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$4.17M
2
ROST icon
Ross Stores
ROST
+$3.43M
3
EA icon
Electronic Arts
EA
+$3.28M
4
MU icon
Micron Technology
MU
+$3.26M
5
ELV icon
Elevance Health
ELV
+$3.19M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$5.01M
2
LNC icon
Lincoln National
LNC
+$4.21M
3
VONV icon
Vanguard Russell 1000 Value ETF
VONV
+$3.89M
4
VZ icon
Verizon
VZ
+$3.16M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.03M

Sector Composition

Rank Sector Weight
1 Technology 17.14%
2 Financials 14.05%
3 Healthcare 11.96%
4 Industrials 6.93%
5 Consumer Staples 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATAI icon
501
AtaiBeckley Inc
ATAI
$2.66B
$97K 0.01%
+19,109
New +$106K
PRHI
502
Presurance Holdings
PRHI
$18.2M
$96K 0.01%
5,772
CERS icon
503
Cerus
CERS
$468M
$73K 0.01%
13,253
+1,243
+10% +$6.88K
RIG icon
504
Transocean
RIG
$5.71B
$52K 0.01%
+11,333
New +$43.1K
GNW icon
505
Genworth Financial
GNW
$3.72B
$47K 0.01%
12,486
ADAM
506
Adamas Trust
ADAM
$856M
$39K ﹤0.01%
2,639
-316
-11% -$4.62K
ZIVO
507
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$39K ﹤0.01%
1,667
DMK
508
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$33K ﹤0.01%
834
-1,214
-59% -$52.1K
FTFT icon
509
Future FinTech Group
FTFT
$1.57M
$10K ﹤0.01%
+16
New +$10.8K
ZIVOW
510
DELISTED
Zivo Bioscience, Inc. Warrants
ZIVOW
$6K ﹤0.01%
10,000
ABT icon
511
CALL
Abbott
ABT
$187B
-400
Closed -$50K
BABA icon
512
CALL
Alibaba
BABA
$304B
-1,000
Closed -$120K
BABA icon
513
Alibaba
BABA
$304B
-873
Closed -$104K
BIP icon
514
Brookfield Infrastructure Partners
BIP
$17.9B
-6,473
Closed -$262K
BNY
515
Bank of New York Mellon
BNY
$108B
-3,914
Closed -$227K
C icon
516
CALL
Citigroup
C
$224B
-2,000
Closed -$125K
ES icon
517
Eversource Energy
ES
$27.1B
-2,271
Closed -$207K
ESS icon
518
Essex Property Trust
ESS
$18.3B
-2,309
Closed -$813K
GPC icon
519
Genuine Parts
GPC
$18.3B
-2,584
Closed -$362K
ITA icon
520
iShares US Aerospace & Defense ETF
ITA
$14.6B
-2,025
Closed -$208K
IUSG icon
521
iShares Core S&P US Growth ETF
IUSG
$33.4B
-1,775
Closed -$205K
IVR icon
522
Invesco Mortgage Capital
IVR
$758M
-2,695
Closed -$75K
IVW icon
523
iShares S&P 500 Growth ETF
IVW
$77B
-2,540
Closed -$213K
IYW icon
524
iShares US Technology ETF
IYW
$24.8B
-1,904
Closed -$219K
MASI
525
DELISTED
Masimo
MASI
-818
Closed -$239K

Similar funds

Verdence Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Verdence Capital Advisors held 549 positions worth $883M, up 3.9% from $850M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Verdence Capital Advisors deployed $65.7M of net new capital in Q1 2022, opening 44 new positions and adding to 336 existing holdings. Its largest new stake was KLA: 111,570 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was TSMC, an estimated $5.01M trimmed.

  • Verdence Capital Advisors's largest Q1 2022 buy was KLA: 111,570 shares worth $4.08M.
  • Verdence Capital Advisors added most to Micron Technology in Q1 2022, an estimated $3.26M increase.
  • Verdence Capital Advisors's biggest Q1 2022 reduction was TSMC, cutting an estimated $5.01M.
  • Verdence Capital Advisors fully exited Howard Bancorp, Inc. Common Stock in Q1 2022, selling an estimated $1.64M.
  • Verdence Capital Advisors's ten largest holdings make up 21% of its $883M portfolio in Q1 2022.
  • Verdence Capital Advisors opened 44 new positions and closed 39 in Q1 2022.
  • Verdence Capital Advisors's portfolio value rose 3.9% quarter-over-quarter to $883M.

Based on Verdence Capital Advisors's 13F filing for Q1 2022, filed 2 May 2022.